WHEELER REAL ESTATE INVESTME (WHLR)

US9630258617 - REIT

4.05  +0.06 (+1.5%)

After market: 4.0007 -0.05 (-1.22%)

Fundamental Rating

2

Taking everything into account, WHLR scores 2 out of 10 in our fundamental rating. WHLR was compared to 130 industry peers in the Diversified REITs industry. While WHLR is still in line with the averages on profitability rating, there are concerns on its financial health. WHLR does not seem to be growing, but still is valued expensively.



4

1. Profitability

1.1 Basic Checks

WHLR had negative earnings in the past year.
In the past year WHLR had a positive cash flow from operations.
WHLR had negative earnings in each of the past 5 years.
WHLR had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -6.21%, WHLR is not doing good in the industry: 89.84% of the companies in the same industry are doing better.
With a Return On Equity value of -163.14%, WHLR is not doing good in the industry: 96.88% of the companies in the same industry are doing better.
WHLR has a Return On Invested Capital of 3.85%. This is in the better half of the industry: WHLR outperforms 74.22% of its industry peers.
The Average Return On Invested Capital over the past 3 years for WHLR is in line with the industry average of 3.08%.
The last Return On Invested Capital (3.85%) for WHLR is above the 3 year average (3.22%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -6.21%
ROE -163.14%
ROIC 3.85%
ROA(3y)-3.45%
ROA(5y)-3.39%
ROE(3y)-25.9%
ROE(5y)-21.3%
ROIC(3y)3.22%
ROIC(5y)3.13%

1.3 Margins

With a decent Operating Margin value of 30.32%, WHLR is doing good in the industry, outperforming 67.19% of the companies in the same industry.
In the last couple of years the Operating Margin of WHLR has grown nicely.
Looking at the Gross Margin, with a value of 66.12%, WHLR is in line with its industry, outperforming 42.97% of the companies in the same industry.
In the last couple of years the Gross Margin of WHLR has declined.
Industry RankSector Rank
OM 30.32%
PM (TTM) N/A
GM 66.12%
OM growth 3Y-5.13%
OM growth 5Y9.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.53%
GM growth 5Y-1.67%

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so WHLR is destroying value.
The number of shares outstanding for WHLR has been increased compared to 1 year ago.
Compared to 5 years ago, WHLR has more shares outstanding
The debt/assets ratio for WHLR is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -0.44, we must say that WHLR is in the distress zone and has some risk of bankruptcy.
WHLR has a Altman-Z score of -0.44. This is amonst the worse of the industry: WHLR underperforms 91.41% of its industry peers.
WHLR has a Debt/Equity ratio of 18.96. This is a high value indicating a heavy dependency on external financing.
WHLR's Debt to Equity ratio of 18.96 is on the low side compared to the rest of the industry. WHLR is outperformed by 96.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 18.96
Debt/FCF N/A
Altman-Z -0.44
ROIC/WACC0.88
WACC4.35%

2.3 Liquidity

WHLR has a Current Ratio of 1.60. This is a normal value and indicates that WHLR is financially healthy and should not expect problems in meeting its short term obligations.
WHLR has a better Current ratio (1.60) than 66.41% of its industry peers.
WHLR has a Quick Ratio of 1.60. This is a normal value and indicates that WHLR is financially healthy and should not expect problems in meeting its short term obligations.
WHLR has a Quick ratio of 1.60. This is in the better half of the industry: WHLR outperforms 69.53% of its industry peers.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.6

2

3. Growth

3.1 Past

WHLR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -449.43%.
The Revenue has been growing slightly by 0.13% in the past year.
The Revenue has been growing by 9.41% on average over the past years. This is quite good.
EPS 1Y (TTM)-449.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-501.04%
Revenue 1Y (TTM)0.13%
Revenue growth 3Y18.82%
Revenue growth 5Y9.41%
Sales Q2Q%-1.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

WHLR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, WHLR is valued cheaply inside the industry as 95.31% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.92

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

WHLR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

WHEELER REAL ESTATE INVESTME

NASDAQ:WHLR (12/20/2024, 8:00:01 PM)

After market: 4.0007 -0.05 (-1.22%)

4.05

+0.06 (+1.5%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-05 2024-11-05/amc
Earnings (Next)N/A N/A
Inst Owners13.95%
Inst Owner Change-59.72%
Ins Owners0.01%
Ins Owner Change0%
Market Cap5.31M
Analysts43.33
Price TargetN/A
Short Float %N/A
Short Ratio0.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF N/A
P/OCF 0.2
P/B 0.21
P/tB 0.42
EV/EBITDA 7.92
EPS(TTM)-266.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)20.22
OCFY499.29%
SpS78.78
BVpS19.58
TBVpS9.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.21%
ROE -163.14%
ROCE 4.87%
ROIC 3.85%
ROICexc 4.08%
ROICexgc 4.18%
OM 30.32%
PM (TTM) N/A
GM 66.12%
FCFM N/A
ROA(3y)-3.45%
ROA(5y)-3.39%
ROE(3y)-25.9%
ROE(5y)-21.3%
ROIC(3y)3.22%
ROIC(5y)3.13%
ROICexc(3y)3.36%
ROICexc(5y)3.23%
ROICexgc(3y)3.41%
ROICexgc(5y)3.27%
ROCE(3y)4.07%
ROCE(5y)3.96%
ROICexcg growth 3Y2.58%
ROICexcg growth 5Y14.46%
ROICexc growth 3Y1.7%
ROICexc growth 5Y14.04%
OM growth 3Y-5.13%
OM growth 5Y9.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.53%
GM growth 5Y-1.67%
F-Score5
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 18.96
Debt/FCF N/A
Debt/EBITDA 8.48
Cap/Depr 103.79%
Cap/Sales 26.22%
Interest Coverage 1.22
Cash Conversion 46.18%
Profit Quality N/A
Current Ratio 1.6
Quick Ratio 1.6
Altman-Z -0.44
F-Score5
WACC4.35%
ROIC/WACC0.88
Cap/Depr(3y)288.53%
Cap/Depr(5y)178.31%
Cap/Sales(3y)74.03%
Cap/Sales(5y)46.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-449.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-501.04%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.13%
Revenue growth 3Y18.82%
Revenue growth 5Y9.41%
Sales Q2Q%-1.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.24%
EBIT growth 3Y12.72%
EBIT growth 5Y19.52%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y99.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-13.1%
OCF growth 3Y9.88%
OCF growth 5Y-0.99%